Section Arrow
BBLG.NASDAQ
- Bone Biologics Corp
Quotes are at least 15-min delayed:2026/03/27 17:31 EDT
After Hours
Last
 1.1
-0.01 (-0.90%)
Bid
1.11
Ask
1.13
High 1.11 
Low 1.1 
Volume 449 
Regular Hours (Closed)
Last
 1.11
-0.0048 (-0.43%)
Day High 
1.125 
Prev. Close
1.1148 
1-M High
1.36 
Volume 
6.85K 
Bid
1.11
Ask
1.13
Day Low
1.11 
Open
1.125 
1-M Low
1.1009 
Market Cap 
2.00M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.18 
20-SMA 1.21 
50-SMA 1.36 
52-W High 6.75 
52-W Low 1.1009 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.65/-1.62
Enterprise Value
2.00M
Balance Sheet
Book Value Per Share
3.00
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ARTLArtelo Biosciences Inc10.54+7.35+230.41%-- 
After Hours 8.52 -2.02 -19.17%
ONCOOnconetix Inc1.94-1.28-39.75%0PE
After Hours 1.82 -0.12 -6.19%
ITRMIterum Therapeutics plc0.0356-0.1404-79.77%-- 
After Hours 0.0472 +0.0116 +32.58%
RCKTRocket Pharmaceuticals3.77-0.92-19.62%-- 
After Hours 3.7501 -0.0199 -0.53%
ADMAADMA Biologics9.25+0.96+11.58%13.87PE
After Hours 9.25 0 0.00%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.